Vaginal self-sampling for non-attenders v1.1

  • Research type

    Research Study

  • Full title

    Vaginal self-sampling for high-risk HPV detection in women who do not attend cervical screening.

  • IRAS ID

    172483

  • Contact name

    Mary McMenamin

  • Contact email

    mary.mcmenamin2@westhealth.n-i.nhs.uk

  • Sponsor organisation

    WHSCT

  • Duration of Study in the UK

    1 years, 6 months, 2 days

  • Research summary

    Cervical cytology screening coverage in Northern Ireland (the proportion of eligible women, aged 25-64 years who have had a test result recorded in the previous five years) has increased steadily since 2005 to 78% in 2012/2013; almost reaching the 80% coverage target. The uptake of cervical screening among women in the 25-29 year age group in Northern Ireland however, has remained consistently lower (70-73%) than all other age groups except for the 60-64 year age group where the coverage rate is similar. The main barriers preventing women from attending for cervical screening are: embarrassment; inconvenience; time and discomfort associated with obtaining cervical samples. Studies have shown that offering women the opportunity to collect a vaginal self-sample to test for HPV (the main risk factor for cervical cancer) could increase screening coverage. Non-attenders in the Western and Belfast Health and Social Care Trust area, aged 25-29 years, will be identified by GPs. Letters with information relating to the study and collection devices will be sent to women giving them two options: 1. inviting them to book a normal screening appointment; 2. inviting them to collect a self-sample for HPV testing with either a swab or brush collection device. Participants for receipt of swab or brush will be randomised. Acceptance to participate in the study will be indicated by signed consent. Returned self-collected samples will be HPV tested. If a sample is negative, no further investigation is required and the woman will be encouraged to accept her next screening invitation. If a sample is positive the woman will be encouraged to book a screening appointment. The study will evaluate: impact on screening uptake, acceptance of self-sampling for both devices, practicality and cost-effectiveness of the intervention.

  • REC name

    North West - Preston Research Ethics Committee

  • REC reference

    16/NW/0117

  • Date of REC Opinion

    24 Feb 2016

  • REC opinion

    Further Information Favourable Opinion